Yu Hu

机构：China North Industries Group Corporation (China), Wuhan Union Hospital, Hubei Cancer Hospital, Union Hospital, Huazhong University of Science and Technology, Texas A&M University · ORCID：0000-0002-2815-4568

发表论文 772 篇 · 总被引 34808 次 · h-index 79

代表论文

• Progress in Pharmacokinetics, Pharmacological Effects, and Molecular Mechanisms of Swertiamarin: A Comprehensive Review (2025 · Cells · 被引 7)
• A fast crashworthiness assessment framework: Sectional force-based multi-stage physics informed surrogate model (2025 · Advances in Engineering Software · 被引 5)
• Beyond hemostasis, the immunomodulatory nature of platelets (2025 · Research and Practice in Thrombosis and Haemostasis · 被引 5)
• Integrin αvβ8–mediated TGF-β1 activation regulates the sustained response in immune thrombocytopenia after TPO-RA withdrawal (2025 · Blood · 被引 4)
• Nanoparticle-Mediated “Cut-Off and Clean-Up” Strategy for Neutrophil Manipulation in Acute Lung Injury Therapy (2025 · ACS Nano · 被引 3)
• China Expert consensus on the application of metagenomic next-generation sequencing for the etiological diagnosis of infections in hematological disorders (2024) (2025 · Blood Science · 被引 3)